Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur J Biochem ; 268(5): 1280-8, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11231279

RESUMEN

Golgi alpha-mannosidase II is an enzyme that processes the intermediate oligosaccharide Gn(1)M(5)Gn(2) to Gn(1)M(3)Gn(2) during biosynthesis of N-glycans. Previously, we isolated a cDNA encoding a protein homologous to alpha-mannosidase II and designated it alpha-mannosidase IIx. Here, we show by immunocytochemistry that alpha-mannosidase IIx resides in the Golgi in HeLa cells. When coexpressed with alpha-mannosidase II, alpha-mannosidase IIx colocalizes with alpha-mannosidase II in COS cells. A protein A fusion of the catalytic domain of alpha-mannosidase IIx hydrolyzes a synthetic substrate, 4-umbelliferyl-alpha-D-mannoside, and this activity is inhibited by swainsonine. [(3)H]glucosamine-labeled Chinese hamster ovary cells overexpressing alpha-mannosidase IIx show a reduction of M(6)Gn(2) and an accumulation of M(4)Gn(2). Structural analysis identified M(4)Gn(2) to be Man alpha 1-->6(Man alpha 1-->2Man alpha 1-->3)Man beta 1-->4GlcNAc beta 1-->4GlcNAc. The results suggest that alpha-mannosidase IIx hydrolyzes two peripheral Man alpha 1-->6 and Man alpha 1-->3 residues from [(Man alpha 1-->6)(Man alpha 1-->3)Man alpha 1-->6](Man alpha 1-->2Man alpha 1-->3)Man beta 1-->4GlcNAc beta 1-->4GlcNAc, during N-glycan processing.


Asunto(s)
Disacáridos/metabolismo , Aparato de Golgi/enzimología , Manosidasas/metabolismo , Polisacáridos/metabolismo , Animales , Células CHO , Células COS , Conformación de Carbohidratos , Secuencia de Carbohidratos , Cromatografía Líquida de Alta Presión , Cricetinae , Disacáridos/química , Técnica del Anticuerpo Fluorescente , Aparato de Golgi/metabolismo , Células HeLa , Humanos , Inmunohistoquímica , Manosidasas/antagonistas & inhibidores , Manosidasas/genética , Ratones , Polisacáridos/química , Proteínas Recombinantes de Fusión/metabolismo , Proteína Estafilocócica A/genética , Proteína Estafilocócica A/metabolismo , Swainsonina/farmacología , Transfección
2.
Glycoconj J ; 18(6): 475-85, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12084983

RESUMEN

Renal cell carcinoma (RCC) has been characterized by high expression of three types of disialogangliosides: two based on lacto-series type 1 structure (disialosyl Lc(4), GalNAc disialosyl Lc(4)), the other based on globo-series structure (disialosyl globopentaosylceramide; disialosyl Gb5). The present study established a mAb, 5F3, directed to disialosyl Gb5. 5F3 was established after immunization with RCC cell line ACHN. The major disialoganglioside antigen isolated from ACHN cells, showing specific reactivity with 5F3, was characterized unequivocally as disialosyl Gb5 (V(3)NeuAcIV(6)NeuAcGb5) by identification of the core structure as globopentaosylceramide (Gb5) after enzymatic and acid hydrolysis, and by 2-dimensional (1)H-NMR spectroscopy. 5F3 does not react with monosialosyl Gb5 (V(3)NeuAcGb5), Gb5, or any lacto-series structures. 5F3 strongly stained 19 of 41 cases of primary RCC tissue. It reacted with proximal tubules (but not distal tubules) of kidney, microglial cells of cerebrum and cerebellum, goblet cells of stomach and intestine, smooth muscle of various organs. It did not react with parenchymatous cells of various organs, except for kidney epithelia and prostate stroma. Immunostaining of RCC tissue by mAb 5F3, in combination with staining by other antibodies directed to globo-series and lacto-series structures, has prognostic significance in defining metastatic potential of RCC.


Asunto(s)
Anticuerpos Monoclonales/inmunología , Antígenos de Neoplasias/inmunología , Carcinoma de Células Renales/química , Carcinoma de Células Renales/inmunología , Gangliósidos/análisis , Gangliósidos/inmunología , Especificidad de Anticuerpos , Carcinoma de Células Renales/diagnóstico , Carcinoma de Células Renales/patología , Línea Celular , Ensayo de Inmunoadsorción Enzimática , Citometría de Flujo , Glicoesfingolípidos/inmunología , Humanos , Inmunohistoquímica , Espectroscopía de Resonancia Magnética , Metástasis de la Neoplasia , Especificidad de Órganos , Pronóstico , Células Tumorales Cultivadas
3.
Gene Ther ; 7(4): 314-20, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10694812

RESUMEN

The Wiskott-Aldrich syndrome (WAS) is an uncommon X-linked recessive disease characterized by thrombocytopenia, eczema and immunodeficiency. The biochemical defect of this disorder primarily affects cells derived from bone marrow. To understand better the molecular mechanisms underlying this disease and to evaluate the possibility of correcting the genetic defects in hematopoietic cells, a Moloney murine leukemia virus (MoMLV)- based retroviral vector carrying a functional Wiskott-Aldrich syndrome protein (WASp) cDNA driven by an SV40 promoter (LNS-WASp) was constructed. A packaging cell line containing this vector produced a stable level of WAS protein and maintained a high titer of viral output. Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines (B-LCL) from WAS patients, which lack expression of the WAS protein, were transduced by the LNS-WASp retroviral vector and showed expression of WASp by Western blot. Analysis of the O-glycan pattern on cell surface glycoproteins from WAS patients' B-LCL showed an altered glycosylation pattern, due to increased activity of beta-1, 6-N-acetylglucosaminyltransferase (C2GnT). Transduction by the retroviral vector carrying the functional WASp cDNA partially restored the abnormal glycosylation pattern, and was accompanied by a decreasing C2GnT activity. These findings imply a functional linkage between the WAS protein and the expression of the glycosyltransferase involved in the O-glycosylation, and also suggest a potential gene therapy via transferring a functional WASp cDNA into hematopoietic cells for Wiskott-Aldrich syndrome. Gene Therapy (2000) 7, 314-320.


Asunto(s)
Glicoproteínas de Membrana/genética , Proteínas/genética , Síndrome de Wiskott-Aldrich/genética , Células Cultivadas , Técnicas de Transferencia de Gen , Vectores Genéticos/genética , Células Madre Hematopoyéticas/fisiología , Humanos , Virus de la Leucemia Murina/genética , Fenotipo , Proteína del Síndrome de Wiskott-Aldrich
4.
Cell ; 90(1): 157-67, 1997 Jul 11.
Artículo en Inglés | MEDLINE | ID: mdl-9230311

RESUMEN

Alpha-mannosidase-II (alphaM-II) catalyzes the first committed step in the biosynthesis of complex asparagine-linked (N-linked) oligosaccharides (N-glycans). Genetic deficiency of alphaM-II should abolish complex N-glycan production as reportedly does inhibition of alphaM-II by swainsonine. We find that mice lacking a functional alphaM-II gene develop a dyserythropoietic anemia concurrent with loss of erythrocyte complex N-glycans. Unexpectedly, nonerythroid cell types continued to produce complex N-glycans by an alternate pathway comprising a distinct alpha-mannosidase. These studies reveal cell-type-specific variations in N-linked oligosaccharide biosynthesis and an essential role for alphaM-II in the formation of erythroid complex N-glycans. alphaM-II deficiency elicits a phenotype in mice that correlates with human congenital dyserythropoietic anemia type II.


Asunto(s)
Anemia Diseritropoyética Congénita/enzimología , Manosidasas/deficiencia , Oligosacáridos/biosíntesis , Alelos , Anemia Diseritropoyética Congénita/genética , Animales , Asparagina , Secuencia de Carbohidratos , Modelos Animales de Enfermedad , Membrana Eritrocítica/metabolismo , Exones , Mutación del Sistema de Lectura , Biblioteca de Genes , Glucolípidos/sangre , Glucolípidos/química , Glucolípidos/aislamiento & purificación , Células Madre Hematopoyéticas , Humanos , Manosidasas/genética , Ratones , Ratones Noqueados , Datos de Secuencia Molecular , Oligosacáridos/química , Fenotipo
6.
J Biol Chem ; 270(37): 21984-90, 1995 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-7665620

RESUMEN

The human megakaryocyte potentiating factor (hMPF) has been previously purified from a culture supernatant of human pancreatic cancer cells HPC-Y5 (Yamaguchi, N., Hattori, K., Oh-eda, M., Kojima, T., Imai, N., and Ochi, N. (1994) J. Biol. Chem. 269, 805-808). We have now isolated hMPF cDNA from a HPC-Y5 cDNA library using polymerase chain reaction and plaque hybridization methods. The hMPF cDNA encodes a polypeptide consisting of 622 amino acids, including a signal peptide of 33 amino acids, and with a deduced molecular mass of 68 kDa, although HPC-Y5 cells secrete a 33-kDa form of hMPF. Human MPF does not show any significant homology with other previously described sequences. The cDNA was expressed in COS-7 and Chinese hamster ovary (CHO) cells, and megakaryocyte potentiating activity was detected in their culture supernatant. The COS-7 cells secreted only a 33-kDa recombinant hMPF, whereas an additional 30-kDa form was detected in the culture medium of CHO cells. The 33-kDa rhMPF purified from CHO cells showed megakaryocyte potentiating activity, but not the purified 30-kDa rhMPF. The difference in structure and activity between the 33- and 30-kDa forms of hMPF was ascribed to the existence in the 33-kDa form of the C-terminal 25 amino acid residues.


Asunto(s)
ADN Complementario/metabolismo , Megacariocitos/fisiología , Biosíntesis de Proteínas , Secuencia de Aminoácidos , Animales , Anticuerpos , Anticuerpos Monoclonales , Secuencia de Bases , Células CHO , Chlorocebus aethiops , Clonación Molecular , Cricetinae , Cartilla de ADN , Proteínas Ligadas a GPI , Humanos , Immunoblotting , Megacariocitos/efectos de los fármacos , Glicoproteínas de Membrana , Mesotelina , Ratones/inmunología , Datos de Secuencia Molecular , Especificidad de Órganos , Proteínas/aislamiento & purificación , Proteínas/farmacología , ARN Mensajero/análisis , ARN Mensajero/biosíntesis , Conejos/inmunología , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/farmacología , Transfección
7.
J Biochem ; 115(2): 345-50, 1994 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8206884

RESUMEN

A glycosylated form of human interleukin 6 (hIL-6) has been produced in Chinese hamster ovary (CHO) cells transfected with a cDNA clone for human IL-6. Recombinant hIL-6 was purified from a culture supernatant of the transfected CHO cells, and used for structural characterization. The complete amino acid sequence, composed of 185 amino acid residues, was determined and is identical to that predicted from the cDNA sequence. However, a recombinant hIL-6 species lacking two amino acid residues (Ala-Pro) from the N-terminus was also found. Two disulfide bonds are formed, between Cys45 and Cys51 and between Cys74 and Cys84. Recombinant hIL-6 carries one O-linked carbohydrate chain, and Thr139 is fully O-glycosylated. A portion of recombinant hIL-6 protein carries one N-linked sialooligosaccharide chain, and the N-glycosylation occurs at Asn46. The structure of the N-linked sugar chains was estimated by a combination of sugar mapping and glycosidase digestion. The major structure of the N-linked sugar chain predicted was of a fucosylated biantennary or triantennary complex type. Fucosylated triantennary sugar chains with one or two N-acetyllactosaminyl repeats were also found. The structure of the O-linked sugar chain was determined by 500 mHz 1H-NMR to be NeuAc alpha 2-3Gal beta 1-3(NeuAc alpha 2-6) Gal-NAcol.


Asunto(s)
Interleucina-6/química , Secuencia de Aminoácidos , Aminoácidos/análisis , Animales , Células CHO , Conformación de Carbohidratos , Secuencia de Carbohidratos , Cricetinae , Cricetulus , ADN Complementario/química , ADN Complementario/genética , Electroforesis en Gel de Poliacrilamida , Glicosilación , Humanos , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Proteínas Recombinantes/química , Mapeo Restrictivo , Especificidad por Sustrato , Transfección
8.
J Biol Chem ; 269(2): 805-8, 1994 Jan 14.
Artículo en Inglés | MEDLINE | ID: mdl-8288629

RESUMEN

Sixty-four kinds of cell lines were examined for their ability to produce megakaryocyte potentiating activity by means of conditioned media obtained from a protein-free culture system. Six human tumor cell lines were shown to produce this activity, and the cell line HPC-Y5, established from human pancreatic cancer, was shown to have the highest level of activity. The megakaryocyte potentiating factor (MPF) was purified from an HPC-Y5 conditioned medium by a combination of ion-exchange chromatography, gel filtration and reverse-phase HPLC. The purified MPF showed a megakaryocyte potentiating activity almost equal to human interleukin-6 in the presence of murine interleukin-3 in a colony formation assay with mouse bone marrow cells. The apparent molecular weight of MPF is 32,000 when determined by SDS-polyacrylamide gel electrophoresis. Glycopeptidase F digestion, and amino sugar analysis of the factor demonstrated that MPF is a glycoprotein carrying at least one N-linked sugar chain. The N-terminal amino acid sequence of MPF was determined to be Leu-Ala-Gly-Glu-Thr-Gly-Gln-Glu-Ala-Ala-Pro-Leu- Asp-Gly-Val-Leu-Ala-Asn. The same or homologous amino acid sequence has not been found in known proteins, demonstrating that MPF is a novel cytokine that has megakaryocyte potentiating activity in the murine assay system.


Asunto(s)
Citocinas/aislamiento & purificación , Megacariocitos/citología , Neoplasias Pancreáticas/química , Secuencia de Aminoácidos , Animales , Células de la Médula Ósea , Ensayo de Unidades Formadoras de Colonias , Citocinas/química , Citocinas/farmacología , Humanos , Técnicas In Vitro , Mesotelina , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Peso Molecular , Células Tumorales Cultivadas
9.
Leuk Res ; 17(7): 593-600, 1993 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-7686992

RESUMEN

We have investigated the effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) administration on the leukemogenic potential of L-103 murine leukemic cells. Leukemogenic potential was assessed by comparing the regression lines drawn between the number of inoculated leukemic spleen cells and the mean survival time (MST) of the syngeneic recipients. rhG-CSF injected 2.5 micrograms daily for 14 days reduced the leukemogenic potential of spleen cells of the leukemic mice to 1/200 of the control. This phenomenon was not observed with the leukemic spleen cells treated with r-murine granulocyte-macrophage (rmGM)-CSF in vivo. Cytochemical study indicated that morphologically identifiable blast cells were fewer in the rhG-CSF-treated leukemic spleen. Furthermore, leukemic cells in the rhG-CSF-treated spleen were less proliferative than the control in spite of having more clonogenic cells in the leukemic cell preparation. Cytogenetical analysis showed that chromosome abnormalities found in the original leukemic cells were not altered by rhG-CSF administrations. It also showed that the frequency of the abnormal karyotype was reduced in rhG-CSF-treated leukemic spleen (4/17) as compared with the control (8/8), indicating that the mitotic fraction was smaller in the rhG-CSF-treated leukemic cells. These findings indicate that in addition to the reduced number of leukemic cells in the spleen cell preparation, a reduction of the proliferative capacity of the original leukemic cells is involved in the reduction of leukemogenic potential of leukemic cells treated with rhG-CSF in vivo.


Asunto(s)
Factor Estimulante de Colonias de Granulocitos/farmacología , Leucemia Mieloide/tratamiento farmacológico , Leucemia Mieloide/patología , Animales , Células CHO/fisiología , División Celular/efectos de los fármacos , Aberraciones Cromosómicas , Cricetinae , Factor Estimulante de Colonias de Granulocitos y Macrófagos/farmacología , Humanos , Cariotipificación , Leucemia Mieloide/genética , Masculino , Ratones , Ratones Endogámicos , Trasplante de Neoplasias , Proteínas Recombinantes/farmacología , Bazo/citología , Bazo/fisiología , Células Tumorales Cultivadas/efectos de los fármacos
10.
J Biol Chem ; 267(11): 7703-9, 1992 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-1560005

RESUMEN

Various deglycosylated derivatives of recombinant human erythropoietin (hEPO) were prepared and used to determine the role of the sugar chains in the expression of its biological activity in vivo and in vitro. Three N-linked oligosaccharides of hEPO have been partially or fully removed to obtain N-glycan (NG) (2)-, NG(1)-, and NG(0)-hEPO carrying two, one, and no N-linked sugar chains, respectively. The preparation lacking only O-linked sugar chain O O-glycan (OG) (0)-hEPO was also used. As de-N-glycosylation proceeded, the in vivo activity of the hormone decreased drastically, and the activity of these derivatives was correlated with the number of sialic acids bound to them. On the contrary, the in vitro activity was increased by the de-N-glycosylation; NG(0)-hEPO showed a 3-fold higher specific activity than the intact hormone. This was confirmed by binding experiments of the derivatives to target cells. The in vitro activity and the affinity also correlated with the number of sialic acids bound to the deglycosylated hEPO preparations. On the other hand, OG(0)-hEPO was as active as the intact hormone in vivo and in vitro. In conclusion, the N-linked sugar chains are not required for in vitro activity but required for in vivo activity, acting as anchors for the essential terminal sialic acids. The O-linked sugar chain has no essential role in the biological activity of the hormone in vivo or in vitro.


Asunto(s)
Eritropoyetina/fisiología , Oligosacáridos/metabolismo , Aminoácidos/análisis , Cromatografía en Gel , Cromatografía Líquida de Alta Presión , Dicroismo Circular , Electroforesis en Gel de Poliacrilamida , Eritropoyetina/química , Glicosilación , Humanos , Mapeo Peptídico
11.
J Nutr Sci Vitaminol (Tokyo) ; Spec No: 337-40, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-1284302

RESUMEN

1. The carbohydrate chain protects rhG-CSF from polymerization and/or conformational alterations associated with physicochemical changes, elevation of pH or temperature fluctuations. 2. The carbohydrate chain of rhG-CSF prevents loss of its biological activity in normal human serum by inhibiting proteinase activity. 3. These facts indicate that the carbohydrate chain of rhG-CSF has a markedly important role in maintaining the stability of the protein itself as well as in effecting the exertion of its biological activity.


Asunto(s)
Carbohidratos/química , Factor Estimulante de Colonias de Granulocitos/química , Ensayo de Unidades Formadoras de Colonias , Estabilidad de Medicamentos , Escherichia coli/química , Glicosilación , Factor Estimulante de Colonias de Granulocitos/sangre , Humanos , Concentración de Iones de Hidrógeno , Proteínas Recombinantes/química
12.
Eur J Biochem ; 194(2): 457-62, 1990 Dec 12.
Artículo en Inglés | MEDLINE | ID: mdl-2269277

RESUMEN

Various partially or fully desialylated human erythropoietins were obtained by neuraminidase digestion of the hormone, without non-specific proteolysis and degradation of carbohydrates. Asialoerythropoietin showed a specific activity of 220-IU/mg protein in vivo, although that of the intact erythropoietin was 2.2 x 10(5) IU/mg. A linear relationship was found between the logarithm of the specific activity in vivo and the number of sialic acids. The asialoerythropoietin showed a four-times-higher specific activity in vitro compared with intact erythropoietin using mouse bone marrow cells. It also showed an approximately six-times-higher specific activity in a colony-forming assay for the erythroid colony-forming unit and the erythroid burst-forming unit. Partially or fully de-N-glycosylated erythropoietin derivatives also showed lower in vivo activity but higher in vitro activity than the intact erythropoietin, dependent on the number of sialic acids. To clarify the reason for the enhanced biological activity of asialoerythropoietin in vitro, the binding of intact 125I-erythropoietin or 125I-asialoerythropoietin to cells containing specific receptors for the hormone was analyzed. 125I-asialoerythropoietin bound to spleen cells from anemic mice approximately five times faster than did intact 125I-erythropoietin. The amount of 125I-asialoerythropoietin internalized by target cells, measured in the absence of NaN3, was four times higher than that of intact erythropoietin. These results demonstrate that asialoerythropoietin binds to its receptor faster than the intact form. This may be the main reason for the increased activity of asialoerythropoietin in vitro.


Asunto(s)
Eritropoyetina/química , Eritropoyetina/metabolismo , Ácidos Siálicos/química , Ácidos Siálicos/farmacología , Animales , Médula Ósea/metabolismo , Células de la Médula Ósea , Células Cultivadas , Electroforesis en Gel de Poliacrilamida , Células Precursoras Eritroides/metabolismo , Glicosilación , Humanos , Técnicas In Vitro , Ratones , Ácido N-Acetilneuramínico , Mapeo Peptídico , Ácidos Siálicos/metabolismo
13.
J Biol Chem ; 265(20): 11432-5, 1990 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-1694845

RESUMEN

Human granulocyte colony-stimulating factor (hG-CSF) is a glycoprotein carrying one O-linked sugar chain. To clarify the role of the oligosaccharide in hG-CSF, some biological and physicochemical properties of the deglycosylated hG-CSF and the intact factor were compared. Recombinant hG-CSF produced in transfected Chinese hamster ovary cells was sequentially digested with neuraminidase and endo-alpha-N-acetylgalactosaminidase. The deglycosylated hG-CSF was one-third as active as the intact form in the colony-forming assay, but it was almost as active as the intact hG-CSF in the cell proliferation assay using NFS-60 cells (NFS-60 bioassay). Inactivation of the deglycosylated hG-CSF was also found by NFS-60 bioassay after incubation for 2 days at pH values from 7 to 8 and at 37 degrees C. This inactivation was accompanied by polymerization of the factor which did not occur with the glycosylated factor. Circular dichroic and calorimetric analyses demonstrated that the deglycosylated hG-CSF is more sensitive to heat denaturation than the intact form and that the inactivation of both forms of hG-CSF was accompanied by conformational change of the proteins. From these results, it was concluded that the O-linked sugar chain of hG-CSF contributes to the stability of the factor by suppressing polymerization and/or its conformational changes.


Asunto(s)
Factores Estimulantes de Colonias , Glicoproteínas , Aminoácidos/análisis , Animales , División Celular/efectos de los fármacos , Línea Celular , Dicroismo Circular , Factores Estimulantes de Colonias/metabolismo , Factores Estimulantes de Colonias/farmacología , Estabilidad de Medicamentos , Factor Estimulante de Colonias de Granulocitos , Humanos , Sustancias Macromoleculares , Oligosacáridos , Conformación Proteica , Desnaturalización Proteica , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacología , Termodinámica , Transfección
14.
J Biochem ; 107(3): 352-9, 1990 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2341370

RESUMEN

Physicochemical and biological properties of recombinant human erythropoietin (rhEPO) were compared with human urinary erythropoietin (uEPO). uEPO and rhEPO were purified to apparent homogeneity from the urine of patients with aplastic anemia and from the conditioned medium of Chinese hamster ovary (CHO) cells transfected with a cDNA clone for human EPO, respectively. The microheterogeneous nature of both factors, observed on isoelectric focusing, is derived from the difference of the number of terminal sialic acid residues bound to the carbohydrate chains of the EPO molecule. The primary structure of rhEPO, consisting of 165 amino acid residues, was determined, and the C-terminal arginine predicted from the cDNA sequence was confirmed to be missing, as described previously (Recny et al. (1987) J. Biol. Chem. 262, 17156). Three N-glycosylation and one O-glycosylation sites of both factors were determined as Asn24, Asn38, and Asn83 and Ser126, respectively. Two disulfide linkages are located between Cys7 and Cys161, and between Cys29 and Cys33, in both EPOs. Hematogenic potencies of rhEPO and uEPO compared in normal and in partially nephrectomized rats were approximately the same. Both factors also stimulated the colony formation of CFU-E, BFU-E, and CFU-Meg in a dose-dependent manner. From these results, it is concluded that rhEPO produced in CHO cells transfected with cDNA clone for human EPO is indistinguishable from uEPO physicochemically and biologically, and is valuable for further research and for clinical use.


Asunto(s)
Eritropoyetina/análisis , Secuencia de Aminoácidos , Aminoácidos/análisis , Anemia Aplásica/metabolismo , Animales , Células Cultivadas , Fenómenos Químicos , Química Física , Clonación Molecular , Disulfuros/análisis , Electroforesis en Gel de Poliacrilamida , Eritropoyetina/farmacología , Eritropoyetina/orina , Hematopoyesis/efectos de los fármacos , Humanos , Hierro/metabolismo , Radioisótopos de Hierro , Ratones , Datos de Secuencia Molecular , Fragmentos de Péptidos/análisis , Ratas , Proteínas Recombinantes/análisis , Compuestos de Sulfhidrilo/análisis
15.
J Biochem ; 107(3): 486-92, 1990 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-1692828

RESUMEN

Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein which stimulates predominantly neutrophilic granulocyte colony formation in mammals. Natural human G-CSF (hG-CSF) and recombinant hG-CSF produced in Chinese hamster ovary (CHO) cells transfected with the cDNA clone for hG-CSF have been purified to apparent homogeneity for structural and biological comparison. The amino acid sequence of recombinant hG-CSF, composed of 174 amino acid residues, was identical with that of natural hG-CSF and also with the sequence predicted from the cDNA. Both forms of hG-CSF have a free Cys-17 and two intramolecular disulfide linkages, between Cys-36 and Cys-42, and between Cys-64 and Cys-74. The O-glycosylation occurred at Thr-133 in both hG-CSFs. Similar CD spectra were obtained for both hG-CSFs. Additionally, both forms showed almost the same biological activities determined by in vitro colony-forming assay and in vivo assay. It is thus concluded that the recombinant hG-CSF is indistinguishable from its natural counterpart and that the former is valuable for more detailed characterization and clinical use.


Asunto(s)
Factores Estimulantes de Colonias/análisis , Secuencia de Aminoácidos , Aminoácidos/análisis , Animales , Células Cultivadas , Dicroismo Circular , Ensayo de Unidades Formadoras de Colonias , Factores Estimulantes de Colonias/farmacología , Cricetinae , Cricetulus , Disulfuros/análisis , Factor Estimulante de Colonias de Granulocitos , Humanos , Hidrólisis , Datos de Secuencia Molecular , Proteínas Recombinantes/análisis , Proteínas Recombinantes/farmacología , Serina Endopeptidasas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA